181 related articles for article (PubMed ID: 15080785)
1. Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men.
Duschek EJ; Gooren LJ; Netelenbos C
Eur J Endocrinol; 2004 Apr; 150(4):539-46. PubMed ID: 15080785
[TBL] [Abstract][Full Text] [Related]
2. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
Hernández E; Valera R; Alonzo E; Bajares-Lilue M; Carlini R; Capriles F; Martinis R; Bellorin-Font E; Weisinger JR
Kidney Int; 2003 Jun; 63(6):2269-74. PubMed ID: 12753317
[TBL] [Abstract][Full Text] [Related]
3. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
Uebelhart B; Herrmann F; Pavo I; Draper MW; Rizzoli R
J Bone Miner Res; 2004 Sep; 19(9):1518-24. PubMed ID: 15312253
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
Akerlund M; Almström E; Högstedt S; Nabrink M
Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
[TBL] [Abstract][Full Text] [Related]
5. The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men.
Taxel P; Kennedy D; Fall P; Willard A; Shoukri K; Clive J; Raisz LG
Endocr Res; 2000 Aug; 26(3):381-98. PubMed ID: 11019903
[TBL] [Abstract][Full Text] [Related]
6. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3.
Duschek EJ; Gooren LJ; Netelenbos C
Maturitas; 2005 Jul; 51(3):286-93. PubMed ID: 15978972
[TBL] [Abstract][Full Text] [Related]
8. Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men.
Sulcová J; Hill M; Masek Z; Ceska R; Novácek A; Hampl R; Stárka L
Physiol Res; 2001; 50(1):9-18. PubMed ID: 11300231
[TBL] [Abstract][Full Text] [Related]
9. Effect of testosterone enanthate on serum lipoproteins in man.
Anderson RA; Wallace EM; Wu FC
Contraception; 1995 Aug; 52(2):115-9. PubMed ID: 8536448
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian women.
Kung AW; Chao HT; Huang KE; Need AG; Taechakraichana N; Loh FH; Gonzaga F; Sriram U; Ismail NM; Farooqi A; Rachman IA; Crans GG; Wong M; Thiebaud D
J Clin Endocrinol Metab; 2003 Jul; 88(7):3130-6. PubMed ID: 12843154
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women.
Draper MW; Flowers DE; Huster WJ; Neild JA; Harper KD; Arnaud C
J Bone Miner Res; 1996 Jun; 11(6):835-42. PubMed ID: 8725181
[TBL] [Abstract][Full Text] [Related]
12. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
[TBL] [Abstract][Full Text] [Related]
13. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men.
Doran PM; Riggs BL; Atkinson EJ; Khosla S
J Bone Miner Res; 2001 Nov; 16(11):2118-25. PubMed ID: 11697809
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
[TBL] [Abstract][Full Text] [Related]
15. Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.
Zgliczynski S; Ossowski M; Slowinska-Srzednicka J; Brzezinska A; Zgliczynski W; Soszynski P; Chotkowska E; Srzednicki M; Sadowski Z
Atherosclerosis; 1996 Mar; 121(1):35-43. PubMed ID: 8678922
[TBL] [Abstract][Full Text] [Related]
16. Progressive Temporal Change in Serum SHBG, But Not in Serum Testosterone or Estradiol, Is Associated With Bone Loss and Incident Fractures in Older Men: The Concord Health and Ageing in Men Project.
Hsu B; Seibel MJ; Cumming RG; Blyth FM; Naganathan V; Bleicher K; Le Couteur DG; Waite LM; Handelsman DJ
J Bone Miner Res; 2016 Dec; 31(12):2115-2122. PubMed ID: 27363725
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women.
Lasco A; Cannavò S; Gaudio A; Morabito N; Basile G; Nicita-Mauro V; Frisina N
Eur J Endocrinol; 2002 Oct; 147(4):461-5. PubMed ID: 12370106
[TBL] [Abstract][Full Text] [Related]
18. Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.
de Valk-de Roo GW; Stehouwer CD; Meijer P; Mijatovic V; Kluft C; Kenemans P; Cohen F; Watts S; Netelenbos C
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2993-3000. PubMed ID: 10591680
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogenic properties of raloxifene.
Draper MW; Flowers DE; Neild JA; Huster WJ; Zerbe RL
Pharmacology; 1995 Apr; 50(4):209-17. PubMed ID: 7792309
[TBL] [Abstract][Full Text] [Related]
20. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.
van den Beld AW; de Jong FH; Grobbee DE; Pols HA; Lamberts SW
J Clin Endocrinol Metab; 2000 Sep; 85(9):3276-82. PubMed ID: 10999822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
